URSL Angle for Predicting Intraoperative Conversion (URSL-PREDICT)

An Exploratory Predictive Study on the Intraoperative Change of Surgical Methods in Transurethral Ureteroscopy for Ureteral Calculi

This international multicenter retrospective cohort study aims to externally validate the URSL Predictive Angle, a novel CT-derived morphometric parameter, as an imaging biomarker for predicting intraoperative conversion risk during transurethral ureteroscopic lithotripsy (URSL) for ureteral calculi.

Intraoperative conversion is defined as the unanticipated abandonment of the planned endoscopic approach due to unfavorable ureteral anatomy or stone impaction, necessitating recourse to open ureterolithotomy, laparoscopic ureterolithotomy, or ureteral stent placement with planned staged secondary intervention. Such conversions are associated with protracted operative duration, heightened anesthetic exposure, and increased physical, psychological, and financial burdens on patients.

The URSL Predictive Angle is a geometric parameter derived from preoperative coronal CT reformations that quantifies the degree of local ureteral angulation induced by an impacted calculus. Preliminary single-center data demonstrated robust predictive fidelity of this metric with an area under the ROC curve of 0.861 and an optimal discriminatory threshold of 131.8° yielding a sensitivity of 82% and a specificity of 88%.

This study will enroll eligible patients from multiple domestic and international tertiary care hospitals who underwent URSL for ureteral calculi between January 1, 2018, and December 31, 2025. The primary outcome is intraoperative conversion of surgical approach. The predictive performance of the URSL angle will be evaluated using ROC curve analysis with AUC calculation. Propensity score matching and multivariable logistic regression will be employed to address potential confounding.

This study is registered as a patient registry with a cohort model. Data collection is retrospective, involving abstraction from electronic medical records, operative logs, and PACS. A waiver of informed consent has been requested based on the retrospective design, minimal risk determination, stringent anonymization procedures, and impracticability of obtaining individual consent.

Study Overview

• Status: Not yet recruiting
• Conditions: Ureteral Calculi

Detailed Description

This international multicenter retrospective cohort study aims to externally validate the URSL Predictive Angle, a novel CT-derived morphometric parameter, for predicting intraoperative conversion risk during transurethral ureteroscopic lithotripsy (URSL) for ureteral calculi.

BACKGROUND

Transurethral ureteroscopic lithotripsy is the first-line minimally invasive treatment for ureteral calculi. However, in a subset of patients, intraoperative stone impaction, severe ureteral tortuosity, or anatomic variants may prevent successful ureteroscope advancement. In such cases, the surgeon must abandon the planned endoscopic approach and convert to open ureterolithotomy, laparoscopic ureterolithotomy, or temporizing stent placement with staged intervention. These unanticipated conversions increase operative duration, anesthetic exposure, and patient burden.

Currently, preoperative conversion risk assessment relies largely on subjective surgeon judgment, with no objective, reproducible predictive tool available. Existing literature focuses on stone attributes (size, location, Hounsfield units) or ureteral wall thickness, but ureteral geometry remains unexplored.

PRELIMINARY DATA

Our group previously conducted a single-center study developing the URSL Predictive Angle, measured on preoperative coronal CT. This angle quantifies local ureteral angulation caused by an impacted calculus. Preliminary results showed an AUC of 0.877, with an optimal cutoff of 132.1° (sensitivity 80.3%, specificity 89.8%). However, external validation across diverse populations and institutions is needed.

STUDY OBJECTIVES

Primary Objective: To externally validate the predictive performance of the URSL angle as an imaging biomarker for intraoperative conversion risk, assessing AUC, sensitivity, specificity, and optimal threshold.

Secondary Objectives: (1) To evaluate inter-observer agreement and test-retest reliability of URSL angle measurements across international centers; (2) To investigate the incremental predictive value of the URSL angle when combined with stone size, location, and Hounsfield units.

STUDY DESIGN

This is an international multicenter retrospective cohort study. Eligible patient records will be retrieved from January 1, 2018 to December 31, 2025 (eight-year period) from multiple domestic and international tertiary care hospitals with accredited urology services. Consecutive enrollment will be applied.

PARTICIPANT SELECTION

Inclusion Criteria: (1) Age > 18 years; (2) Preoperative imaging confirmation of unilateral ureteral calculi (solitary or multiple, with index stone designated); (3) Planned and attempted URSL as initial treatment; (4) Available preoperative thin-slice CT (≤1.25 mm) in DICOM format with sufficient quality for multiplanar reconstruction.

Exclusion Criteria: (1) No preoperative CT or poor image quality; (2) Incomplete medical records or insufficient operative detail; (3) Prior ipsilateral percutaneous nephrostomy or ureteral stent; (4) Calculi at ureteropelvic junction or ureteral orifice; (5) Prior ipsilateral ureteral surgery or urinary diversion.

GROUP ALLOCATION

Patients will be classified into Conversion Group or Success Group based on intraoperative conversion criteria. Two investigators will independently review operative records, with arbitration by a third senior urologist if disagreement occurs. Indeterminate cases will be excluded.

OUTCOME VARIABLE

Primary Outcome: Intraoperative conversion, defined as unanticipated abandonment of URSL due to technical impediments from unfavorable ureteral anatomy or stone impaction, requiring open ureterolithotomy, laparoscopic ureterolithotomy, or stent placement with staged intervention. Conversions due to equipment failure or non-anatomic causes are excluded.

PREDICTOR VARIABLE

Primary Predictor: URSL Predictive Angle. Standardized measurement protocol: (1) Select coronal plane with maximal stone cross-sectional area; (2) Measure longest stone axis, marking superior and inferior poles as Point A and Point B; (3) Trace 5mm cephalad from Point A along ureteral centerline to Point A'; (4) Trace 5mm caudad from Point B to Point B'; (5) Identify Point C on stone contour farthest from line AB; (6) Calculate ∠A'CB'. The 5mm offset distance balances avoidance of periureteral inflammation while preserving stone-induced deformation. Dual independent measurement with arbitration for discrepancies >5° will be performed.

COVARIATES

Demographic: age, sex, BMI. Stone-related: laterality, multiplicity, location, length, Hounsfield units. Comorbidities: hypertension, diabetes, coronary artery disease. Quality control variables include center code, data abstractor ID, and measurer ID.

SAMPLE SIZE

Sample size was calculated using PASS 2025 based on ROC curve analysis. Parameters: anticipated AUC = 0.80, null AUC = 0.50, α = 0.05 (two-tailed), power = 0.90, event rate = 4%, attrition = 10-15%, multicenter design effect = 1.25. Unadjusted sample size: 1,700 patients (68 Conversion, 1,632 Success). Final target: 2,125 patients (85 expected in Conversion Group).

DATA MANAGEMENT

Data will be collected using a standardized electronic case report form in Excel. Each center will employ dual independent data entry with reconciliation. The coordinating center (The First Hospital of Jilin University) will perform centralized logic checks, range validation, and missing data analysis. All data will be anonymized before transmission. The database will be locked after verification and archived for 10 years.

STATISTICAL ANALYSIS

Analyses will be performed using SPSS 27.0 and R software. P < 0.05 (two-tailed) is considered significant.

Descriptive statistics: Mean ± SD for normal continuous variables; median (IQR) for non-normal; frequencies and percentages for categorical variables.

Propensity score matching (1:3 nearest-neighbor, caliper 0.02) will balance age, sex, BMI, stone laterality, stone location, stone multiplicity, hypertension, diabetes, and coronary artery disease. Balance will be assessed using standardized mean differences (SMD < 0.10).

Univariate analysis in the matched cohort will examine associations with conversion status. Variables with P < 0.10 will enter multivariable logistic regression, with the URSL angle as the primary independent variable.

ROC curve analysis will evaluate discriminatory capacity, with AUC and 95% CI reported using the DeLong method. The Youden index will identify the optimal cutoff, with corresponding sensitivity, specificity, PPV, and NPV.

Missing data: Patients missing primary outcome or predictor will be excluded. Complete-case analysis will be used for covariates.

BIAS MITIGATION

Selection bias: Consecutive enrollment, explicit eligibility criteria, and multicenter participation.

Information bias: Standardized eCRF, uniform imaging protocol, dual independent measurement, outcome blinding during measurement, centralized data verification.

Confounding: Propensity score matching and multivariable regression in the matched cohort.

Center effects: Uniform protocol training, regular inter-center communication, and cross-center measurement consistency audits.

QUALITY MANAGEMENT

Each center will designate a site PI, two data abstractors, and two imaging measurers. Center-level internal audits will verify data fidelity. The coordinating center will perform completeness checks, logical consistency verification, and outlier detection. Inter-observer agreement for imaging measurements will be assessed using ICC, with ICC > 0.80 considered satisfactory.

ETHICAL CONSIDERATIONS

IRB approval will be obtained from the coordinating center and each participating center prior to study initiation. A waiver of informed consent will be requested based on: (1) retrospective design with secondary use of clinical data; (2) minimal risk determination; (3) stringent data anonymization; (4) impracticability of obtaining individual consent across an eight-year international multicenter cohort. The study will comply with the Declaration of Helsinki and applicable privacy regulations (China PIPL, EU GDPR, US HIPAA).

All data will be de-identified, with no direct personal identifiers in the eCRF. Data transmission will be encrypted, and the central database will be password-protected with restricted access. No individual patient or institution will be identifiable in any publication.

• Study Type: Observational
• Enrollment (Estimated): 2200

Contacts and Locations

• Study Contact: Name: Yanbo Wang; Phone Number: 13756469518; Email: wangyanb@jlu.edu.cn

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

All participating centers are required to maintain established expertise in ureteroscopic surgical techniques, robust clinical data management infrastructure, and comprehensive archival systems for preoperative computed tomography imaging. Each center shall formally assent to and comply with the unified study protocol, thereby ensuring data completeness, source traceability, and adherence to international ethical standards.

Eligible patient records will be retrieved for the period spanning January 1, 2018, to December 31, 2025 (inclusive, encompassing an eight-year interval). All patients who underwent URSL for ureteral calculi and satisfied the stipulated eligibility criteria during this timeframe will be considered for inclusion.

Description

Inclusion Criteria:

1. Age > 18 years at the time of surgery, without restriction based on sex, ethnicity, or occupation.
2. Preoperative imaging confirmation of unilateral, solitary, or unilateral multiple ureteral calculi. In cases of ipsilateral multiple stones, the calculus deemed primarily responsible for obstruction or designated as the principal surgical target shall serve as the index stone.
3. Planned and attempted transurethral ureteroscopic lithotripsy as the initial treatment modality.
4. Availability of preoperative thin-slice (section thickness ≤ 1.25 mm) computed tomography urography or non-contrast CT of the urinary tract in native Digital Imaging and Communications in Medicine (DICOM) format, of sufficient diagnostic quality to permit multiplanar reconstruction and precise morphometric analysis. Image data must be complete and free from substantial motion or beam-hardening artifact that would preclude accurate delineation of ureteral anatomy.

Exclusion Criteria:

• 1.Absence of preoperative CT imaging performed at the participating institution; missing, corrupted, or irretrievable DICOM data; or suboptimal image quality that precludes reliable ureteral segmentation and measurement.

  2.Incomplete inpatient medical records lacking essential demographic or baseline clinical data; operative notes containing insufficient procedural detail to definitively ascertain whether intraoperative conversion occurred or to adjudicate the specific etiology thereof.

  3.Prior ipsilateral percutaneous nephrostomy tube placement or ureteral stent indwelling for any indication before the index URSL procedure.

  4.Calculi situated at anatomically distinct locations, specifically the ureteropelvic junction or the ureteral orifice.

  5.Antecedent ipsilateral ureteral surgery (e.g., ureteral reimplantation, prior ureteroscopic lithotripsy) or history of urinary diversion (e.g., ileal conduit). Such patients are excluded because surgical alteration of native ureteral anatomy would confound the morphometric assumptions underlying URSL angle determination.

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort
Success Group; Patients who successfully underwent transurethral ureteroscopic lithotripsy without intraoperative conversion, defined as successful endoscope advancement to the target calculus, completion of lithotripsy and stone extraction, and no deviation from the planned surgical approach due to ureteral conditions or stone characteristics.
Conversion Group; Patients who experienced intraoperative conversion from transurethral ureteroscopic lithotripsy to an alternative surgical modality due to technical impediments attributable to unfavorable ureteral anatomy or stone impaction. Alternative modalities include open ureterolithotomy, laparoscopic ureterolithotomy, or ureteral stent placement with planned staged secondary intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Intraoperative Conversion of Surgical Approach	Unanticipated abandonment of the planned transurethral ureteroscopic lithotripsy procedure due to technical impediments directly attributable to unfavorable ureteral anatomy or calculus impaction, necessitating intraoperative recourse to an alternative surgical modality. Alternative modalities include open ureterolithotomy, laparoscopic ureterolithotomy, or ureteral stent placement with planned staged secondary intervention. Conversions due to equipment malfunction, hemodynamic instability, or other non-anatomic etiologies are excluded. Outcome will be ascertained by retrospective review of operative records.	At the time of surgery, as documented in the operative record

Collaborators and Investigators

• Sponsor: The First Hospital of Jilin University

Publications and helpful links

General Publications

• Turk C, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2016 Mar;69(3):475-82. doi: 10.1016/j.eururo.2015.07.041. Epub 2015 Sep 4.
• Brisbane W, Bailey MR, Sorensen MD. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016 Nov;13(11):654-662. doi: 10.1038/nrurol.2016.154. Epub 2016 Aug 31.
• Li Y, Chen Y, Liu X, Chen J, Gan T, Zhang H. Patient Pain and Function After Correction of Posterior Malleolar Malunion. Foot Ankle Int. 2021 Dec;42(12):1536-1546. doi: 10.1177/10711007211017831. Epub 2021 Jul 1.
• Okada Y, Kohara K, Ochi M, Nagai T, Tabara Y, Igase M, Miki T. Mechanical stresses, arterial stiffness, and brain small vessel diseases: Shimanami Health Promoting Program Study. Stroke. 2014 Nov;45(11):3287-92. doi: 10.1161/STROKEAHA.114.006539. Epub 2014 Sep 16.

Study record dates

Study Major Dates

• Study Start (Estimated): June 1, 2026
• Primary Completion (Estimated): August 1, 2026
• Study Completion (Estimated): September 30, 2026

Study Registration Dates

• First Submitted: April 24, 2026
• First Submitted That Met QC Criteria: April 24, 2026
• First Posted (Actual): May 1, 2026

Study Record Updates

• Last Update Posted (Actual): May 1, 2026
• Last Update Submitted That Met QC Criteria: April 24, 2026
• Last Verified: January 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Urogenital Diseases; Male Urogenital Diseases; Calculi; Pathological Conditions, Anatomical; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urolithiasis; Urinary Calculi; Ureteral Diseases; Pathological Conditions, Signs and Symptoms; Ureterolithiasis; Ureteral Calculi
• Other Study ID Numbers: JLU-Wyb

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: Whether individual participant data will be shared has not yet been determined. A final decision regarding data sharing will be made after study completion, taking into consideration institutional policies, ethical approvals, and applicable data protection regulations. Any data sharing, if implemented, will require a signed data use agreement and will ensure that all shared data are fully de-identified to protect participant privacy.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No